Find information on thousands of medical conditions and prescription drugs.

Nalbuphine

Nalbuphine (nalbuphine hydrochloride) is a synthetic opioid used commercially as an analgesic under a variety of trade names, including Nubain. It is noteworthy in part for the fact that at low dosages, it is found much more effective by women than by men, and may even increase pain in men.

Nalbuphine has been discontinued since 2003 in the UK.

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
Nabilone
Nadolol
Nafarelin
Nafcillin
Nalbuphine
Nalidixic acid
Nallpen
Naloxone
Naltrexone
Nandrolone
Naphazoline
Naprelan
Naprosyn
Naproxen
Naratriptan
Narcan
Nardil
Naropin
Nasacort
Nasalcrom
Nascobal
Natamycin
Navane
Navelbine
Nebcin
Nebracetam
Nefazodone
Nefiracetam
Nelfinavir
Nembutal
Neoarsphenamine
Neomycin
Neoral
Neosporin
Neulasta
Neupogen
Neurontin
Nevirapine
Nexium
Nialamide
Niaspan
Niclosamide
Nicoderm
Nicorette
Nicotinamide
Nicotine
Nicotinic acid
Nicotrol
Nifedipine
Nifehexal
Nikethamide
Nilstat
Nilutamide
Nimesulide
Nimodipine
Nimotop
Nitrazepam
Nitrofurantoin
Nix
Nizatidine
Nizoral
Nocodazole
Nolvadex
Nomifensine
Norco
Nordazepam
Nordette
Norepinephrine
Norethin
Norfloxacin
Norgestimate
Norgestrel
Norinyl
Noritate
Normodyne
Norplant
Norpramin
Nortriptyline
Norvasc
Norvir
Noscapine
Novafed
Novobiocin
Novocain
Novrad
Nuprin
Nysert
Nystaform
Nystatin
Nystex
Nystop
O
P
Q
R
S
T
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


Heroin-related noncardiogenic pulmonary edema : a case series - clinical investigations in critical care
From CHEST, 11/1/01 by Karl A. Sporer

Study objectives: To examine the current clinical spectrum of noncardiogenic pulmonary edema (NCPE) related to heroin overdose.

Design: Retrospective chart review of all identified patients from August 1994 through December 1998.

Setting: Urban academic hospital.

Patients or participants: Heroin-related NCPE was defined as the syndrome in which a patient develops significant hypoxia (room air saturation < 90% with a respiratory rate > 12/min) within 24 h of a clinically apparent heroin overdose. This should be accompanied by radiographic evidence of diffuse pulmonary infiltrates not attributable to other causes, such as cardiac dysfunction, pneumonia, pulmonary embolism, or bronchospasm, and which resolve clinically and radiographically within 48 h.

Interventions: None.

Measurements and results: Twenty-seven patients were identified during this 53-month period, with a majority being male patients (85%; average age, 34 years). Twenty patients (74%) were hypoxic on emergency department arrival, and 6 patients (22%) had symptoms develop within the first hour. One patient had significant hypoxia develop within 4 h. Nine patients (33%) required mechanical ventilation, and all intubated patients but one were extubated within 24 h. Eighteen patients (66%) were treated with supplemental oxygen alone. Hypoxia resolved spontaneously within 24 h in 74% of patients, with the rest (22%) resolving within 48 h. Twenty patients (74%) had classical radiograph findings of bilateral fluffy infiltrates, but unilateral pulmonary edema occurred in four patients (15%) and more localized disease occurred in two patients (7%). Conclusion: NCPE is an infrequent complication of a heroin overdose. The clinical symptoms of NCPE are clinically apparent either immediately or within 4 h of the overdose. Mechanical ventilation is necessary in only 39% of patients. The incidence of NCPE related to heroin overdose has decreased substantially in the last few decades. (CHEST 2001; 120:1628-1632)

Key words: heroin; noncardiogenic; poisoning; pulmonary edema

Abbreviations: ED = emergency department; NCPE = noncardiogenic pulmonary edema; PA = pulmonary artery

**********

Heroin use has increased dramatically in the United States during the past decade, and heroin-related emergency department (ED) visits have increased 110% between 1990 and 1995. (1) In 1996, heroin overdose was responsible for 14,300 ED visits as well as 4,178 deaths. (2)

In certain western cities, the death toll from heroin overdoses has become the largest category of preventable deaths. In San Francisco, more people die of a heroin overdose than all causes of trauma combined. (3) The actual mechanism of death caused by a heroin overdose has never been adequately explained. (4) The one striking finding is the almost universal occurrence of noncardiogenic pulmonary edema (NCPE) in the fatal overdose. (4-6) It is hoped that a better understanding of NCPE in patients with nonfatal heroin overdoses may lead to a partial explanation of the mode of death in a heroin overdose and can lead us in directions that may decrease the death rate from this street drug. An appreciation of the incidence of NCPE in heroin-overdose patients may also give us insight into proper treatment of patients with nonfatal heroin overdoses.

NCPE is a well-Mown severe complication of heroin overdose that was first described by William Oster during an autopsy in 1880. (7) The presentation and clinical course of NCPE patients with nonfatal heroin overdoses were first described (8) in 1953, and later in a variety of case series and reports. (9-28)

A heroin overdose is routinely clinically diagnosed by noting the combination of altered mental status, severely decreased respiratory drive, pinpoint pupils, and circumstantial evidence of drug use. (29) NCPE related to a heroin overdose usually presents as the combination of persistent hypoxia after resolution of opiate respiratory depression along with frothy, pink-tinged pulmonary secretions, and a characteristic radiograph pattern of fluffy diffuse pulmonary infiltrates. Some of these patients require mechanical ventilation to treat their hypoxia. The symptoms usually resolve rapidly with supportive care alone within hours to 1 or 2 days.

NCPE has also been reported with overdoses of methadone, (30) propoxyphene, (31) codeine, (32) buprenorphine, (33,34) and nalbuphine. (35) There is also an unrelated sydrome of cardiogenic pulmonary edema that has been rarely reported with the use of naloxone (36) or nalmefene (37) to reverse therapeutic doses of opiates after anesthesia.

MATERIALS AND METHODS

This study took place at San Francisco General Hospital, an urban hospital with > 75,000 ED visits per year. The University of California, San Francisco Committee of Human Research approved this study.

Most heroin overdoses are diagnosed and initially treated by paramedics. After making the presumptive diagnosis of a heroin overdose (a patient with an abnormal level of consciousness, pinpoint pupils, and decreased or absent respirations), the patient is treated with a bag-valve mask and supplemental oxygen along with an IM dose of naloxone, 2 mg. Approximately 70% of the heroin-overdose patients in San Francisco are transported to San Francisco General Hospital. (38) In the ED, heroin-overdose patients are observed for 2 h for signs of significant resedation, significant hypoxia, fever, or other complications. IV fluids are rarely administered.

We defined opiate-related NCPE as the syndrome in which a patient develops significant hypoxia (room air oxygen saturation < 90% with a respiratory rate > 12/min) within 24 h of a clinically apparent heroin overdose. This should be accompanied by radiographic evidence of diffuse pulmonary infiltrates not attributable to other causes, such as cardiac dysfunction, pneumonia, pulmonary embolism, or bronchospasm, and which resolve clinically and radiographically within 48 h.

A database of all ED patients seen during the period of August 1994 through December 1998 was queried for this study. The absolute number of patients who presented to our ED with the diagnosis of a heroin overdose was determined by searching the diagnosis field with a combination of the terms, "heroin overdose" or "HOD." All of the admissions to the medicine service at our hospital with a test diagnosis containing the words "heroin overdose," "HOD," "heroin," or "opiate" were reviewed. The clinical charts and radiographs of 162 patients were reviewed by one of the authors (E.D.) for appropriateness of the diagnosis of NCPE. Most patients were admitted to the hospital for a variety of other medical reasons, such as pneumonia, possible endocarditis, persistent confusion, cellulitis, etc. Borderline cases (eg, atypical pneumonia)were reviewed by the first author (K.A.S.) for consistency with the diagnosis.

RESULTS

There were 1,278 patients who presented with the diagnosis of heroin overdose in our hospital during this 53-month period; 162 of these patients were admitted to the medical service, and a total of 27 patients met the criteria for the diagnosis of NCPE. There were 23 male patients in this NCPE cohort, and the average age was 34 years. There were no repeat cases among the NCPE group. The repeat rate for all heroin-overdose patients has been shown (38) to be extremely small in our city.

All patients but one received prehospital naloxone. Twenty patients (74%) were hypoxic on presentation to the ED, and 6 patients (22%) had severe hypoxia develop during the first hour. One patient (4%) presented with a room air oxygen saturation of 93% and a respiratory rate of 18/min that worsened within 4 h to a room air oxygen saturation of 81%. Characteristic radiographic findings of pulmonary edema developed in this patient.

There were no episodes of hypoventilation in this group of patients. The respiratory rate ranged from 16 to 44/min (average, 24/min). The initial oxygen saturation ranged from 47 to 89% on room air, with an average oxygen saturation of 76%. Thirty-three percent of these patients required mechanical ventilation to achieve adequate oxygenation, while most of the patients (66%) were treated with oxygen via nonrebreather face mask and observation only. There were three patients who presented with hypotension (systolic BP < 90 mm Hg). These episodes resolved spontaneously with < 500 mL of crystalloid fluid resuscitation.

The hypoxic symptoms of a majority of patients (74%) resolved within 24 h, several within 8 h. The other six patients (22%) had resolution of symptoms within 24 to 48 h. All intubated patients but one were extubated within 24 h. This patient required a prolonged ICU stay partially because of an iatrogenic pneumothorax.

Classic chest radiographic findings of bilateral pulmonary edema were noted in 20 of the 27 patients (74%). Interestingly, four patients presented with chest radiographic findings of unilateral pulmonary edema, a finding that has been previously reported. (14,16,39) Three other patients had chest radiographic findings of "patchy atelectasis" (n = 2) and "nodular interstitial pattern" (n = 1). These patients did not undergo bronchoscopy to definitively rule out aspiration pneumonia, but the absence of an increased WBC count and the very rapid resolution of the symptoms and the radiographic findings make this less likely. Rhabdomyolysis was diagnosed in two of these patients, and they were treated with fluid replacement and sodium bicarbonate. Neither patient developed renal insufficiency.

DISCUSSION

We have presented the clinical characteristics of the largest case series of heroin-related NCPE since the 1960s. NCPE is an infrequent complication of patients who present with an acute heroin overdose. The symptoms of significant hypoxia with an adequate respiratory rate usually occur rapidly after treatment. The radiographic findings are usually bilateral fluffy infiltrates, but a percentage of patients can have unilateral or lobar disease. Only 33% of these patients require intubation. Most patients required only supplemental oxygen, and most of these patients' symptoms resolve within 24 h.

The epidemiology of NCPE has changed over the last 40 years. Earlier retrospective ease series (14,17,18) of heroin-overdose patients admitted to the hospital have described a NCPE rate of 48 to 80%. The full denominator, including heroin-overdose patients admitted to and discharged from the hospital, was not available in these studies. More recent case series (28,40-43) of patients presenting with heroin overdoses have a NCPE rate of 0.8% to 2.4%, similar to our rate of 2.1%.

The decreased rate of NCPE in patients with nonfatal heroin overdoses can be partially explained by including the full denominator of heroin-overdose patients admitted to and discharged from the hospital. But this alone cannot explain all of the difference. These earlier case series (14,17,18) occurred before naloxone was readily available. This specific narcotic antagonist may be instrumental in decreasing the number of patients with nonfatal heroin overdoses with NCPE. The improvement of emergency medical services with the earlier prehospital administration of naloxone and oxygen may also add to this improvement. (41)

This early experience with high rates of NCPE is the likely reason for the extended recommended observation period of 12 to 24 h that is commonly quoted. (14,44) Because NCPE is a relatively uncommon event in heroin-overdose patients and usually presents early, a 1-h to 2-h observation period should be adequate for these patients. One prospective study (43) demonstrated that these patients rarely return to the hospital for subsequent treatment.

The pathophysiology of NCPE related to heroin overdose has never been adequately explained. This is of interest not because of its relative infrequency in nonfatal heroin overdose, but because of its almost universal occurrence in fatal heroin overdose. (4-6) This may suggest that this entity may be a partial explanation for the mode of death in a heroin overdose.

The investigations into the cause of heroin-related NCPE have been limited. Hemodynamic evaluation of a total of 11 patients with heroin-related NCPE demonstrated normal or increased cardiac output, normal pulmonary capillary pressure, and only moderately elevated pulmonary artery (PA) pressure. (24,28,45,46) Pulmonary fluid analysis of patients with this syndrome confirmed a much higher protein concentration, as compared to edema fluid from patients with congestive heart failure, consistent with the hypothesis that leaky pulmonary capillaries and not pump failure are the likely cause of heroin-related NCPE. (45,47)

The only animal model (48) of opiate-induced pulmonary edema examined the effect of morphine on the pulmonary vasculature in perfused, normally oxygenated eats and dogs. A large dose of morphine caused a highly variable increase in pulmonary vascular resistance via venous vasoconstriction. Animals with a mild-to-moderate increase in PA pressure recovered spontaneously and returned to baseline. The animals with a marked increase in PA pressure had pulmonary edema develop within 20 to 30 min. The increase in PA pressure was reversed by chlorpheniramine, a histamine type 1-receptor antagonist. Pretreatment with naloxone blunted this response but had no effect in posttreatment.

Histamine has been implicated as a possible mediator of NCPE related to heroin overdose. Human lungs are rich in histamine, (49) and opiates have been shown to cause its systemic and local release. (50-57) Histamine has been shown (49,58,59) to increase pulmonary lymph flow and capillary permeability. One study of patients with fatal heroin overdoses demonstrated a modest correlation with elevated tryptase levels (a postmortem histamine surrogate), as compared to control subjects. (60)

CONCLUSION

To our knowledge, this is the largest ease series of NCPE reported in several decades. NCPE is an infrequent complication of nonfatal heroin overdoses, with an incidence of 2.1% in our hospital. The symptoms of significant hypoxia with an adequate respiratory rate usually occur rapidly after treatment. The radiographic findings are usually bilateral fluffy infiltrates, but a significant percentage of patients can have unilateral or lobar disease. Only 33% of these patients require mechanical ventilation. A majority of patients only required supplemental oxygen, and symptoms in most of these patients resolved within 24 h.

REFERENCES

(1) Department of Health and Human Services. Year-end preliminary estimates from the 1996 Drug Abuse Warning Network, Rockville, MD: Substance Abuse and Mental Health Services Administration, November 1997

(2) Department of Health and Human Services. Drug Abuse Warning Network: annual medical examiners data, 1995, Rockville, MD: Substance Abuse and Mental Health Services Administration, May 1997

(3) McLoughlin E, Weitzel M, Skaj P, et al. Profile of injury in San Francisco. San Francisco, CA: San Francisco Department of Public Health, 1998

(4) Darke S, Zador D. Fatal heroin "overdose": a review. Addiction 1996; 91:1765-1772

(5) Levine SB, Grimes ET. Pulmonary edema and heroin overdose in Vietnam. Arch Pathol 1973; 95:330-332

(6) Karch SB. Narcotics. In: The pathology of drug abuse. 2nd ed. Boca Raton, FL: CRC Press; 1997; 281-407

(7) Sternbach G. William Osler: narcotic-induced pulmonary edema. J Emerg Med 1983; 1:165-167

(8) Troen P. Pulmonary edema in acute opium intoxication. N Engl J Med 1953; 248:364-366

(9) Silber R, Clerkin EP. Pulmonary edema in acute heroin poisoning. Am J Med 1959; 27:187-192

(10) Selzman HM, Kahil ME, Fred HL. Pulmonary edema accompanying heroin intoxication. Cardiovasc Res Center Bull 1967:6:77-78

(11) Louria DB, Hensle T, Rose J. The major medical complications of heroin addiction. Ann Intern Med 1967; 67:1-22

(12) Cherubin CE. The medical sequelae of narcotic addiction. Ann Intern Med 1067; 67:23-33

(13) Stern WZ, Spear PW, Jacobson HG. The roentgen findings in acute heroin intoxication. AJR Am J Roentgenol 1968; 103: 522-532

(14) Steinberg AD, Karliner JS. The clinical spectrum of heroin pulmonary edema. Arch Intern Med 1968; 122:122-127

(15) Karliner JS, Steinberg AD, Williams MH Jr. Lung function after pulmonary edema associated with heroin overdose. Arch Intern Med 1969; 124:350-353

(16) Jaffe RB, Koschmann EB. Intravenous drug abuse: pulmonary, cardiac, and vascular complications. Am J Roentgenol Radium Ther Nucl Med 1970; 109:107-120

(17) Morrison WJ, Wetherill S, Zyroff J. The acute pulmonary edema of heroin intoxication. Radiology 1970; 97:347-351

(18) Duberstein JL, Kaufman DM. A clinical study of an epidemic of heroin intoxication and heroin-induced pulmonary edema. Am J Med 1971; 51:704-714

(19) Frand UI, Shim CS, Williams MH Jr. Heroin-induced pulmonary edema: sequential studies of pulmonary function. Ann Intern Med 1972; 77:29-35

(20) Addington WW, Cugell DW, Basely ES. The pulmonary edema of heroin toxicity: an example of the stiff lung syndrome. Chest 1972; 62:199-205

(21) Light RW, Dunham TR. Severe slowly resolving heroin-induced pulmonary edema. Chest 1975; 67:61-64

(22) Paranthaman SK, Khan F. Acute cardiomyopathy with recurrent pulmonary edema and hypotension following heroin overdosage. Chest 1976; 69:117-119

(23) Banner AS, Muthuswamy P, Shah RS, et al. Bronchiectasis following heroin-induced pulmonary edema: rapid clearing of pulmonary infiltrates. Chest 1976; 69:552-555

(24) Smith WR, Glauser FL, Dearden LC, et al. Deposits of immunoglobulin and complement in the pulmonary tissue of patients with "heroin lung." Chest 1978; 73:471-476

(25) Leechawengwong M, Berger HW, Jayamanne DS. Long-term serial follow-up after two episodes of heroin-induced adult respiratory distress syndrome. Mt Sinai J Med 1979; 46:119-121

(26) Wang M, Liaw S, Bullard MJ. Heroin lung: report of two cases. J Formosa Med Assoc 1994; 93:170-172

(27) Raijmakers PG, Groeneveld AB, de Groot MC, et al. Delayed resolution of pulmonary oedema after cocaine/heroin abuse. Thorax 1994; 49:1038-1040

(28) Otto D, Franke M, Madden JF. Hypothermia accompanied by noncardiogenic pulmonary edema: a case report. Del Med J 1996; 68:499-502

(29) Sporer KA. Acute heroin overdose. Ann Intern Med 1999; 130:584-590

(30) Kjeldgaard JM, Hahn GW, Heekenlively JR, et al. Methadone-induced pulmonary edema. JAMA 1971; 218:882-883

(31) Bogartz LJ, Miller WC. Pulmonary edema associated with propoxyphene intoxication. JAMA 1971; 215:259-262

(32) Sklar J, Timms RM. Codeine-induced pulmonary edema. Chest 1977; 72:230-231

(33) Gould DB. Buprenorphine causes pulmonary edema just like all other mu-opioid narcotics [letter]. Chest 1995; 107:1478-1479

(34) Thammakumpee G, Sumpatanukule P. Noncardiogenic pulmonary edema induced by sublingual buprenorphine. Chest 1994; 106:306-308

(35) Stadnyk A, Grossman RF. Nalbuphine-induced pulmonary edema. Chest 1986; 90:773-774

(36) Schwartz JA, Koenigsberg MD. Naloxone-induced pulmonary edema. Ann Emerg Med 1987; 16:1294-1296

(37) Henderson CA, Reynolds JE. Acute pulmonary edema in a young male after intravenous nalmefene. Anesth Analg 1997; 84:218-219

(38) Sporer KA, Firestone J, Isaacs SM. Out-of-hospital treatment of opioid overdoses in an urban setting. Acad Emerg Med 1996; 3:660-667

(39) Stern WZ, Subbarao K. Pulmonary complications of drug addiction. Semin Roentgenol 1983; 18:183-197

(40) Smith DA, Leake L, Loflin JR, et al. Is admission after intravenous heroin overdose necessary? Ann Emerg Med 1992; 21:1326-1330

(41) Bertini G. Russo L, Cricelli F, et al. Role of a prehospital medical system in reducing heroin-related deaths. Crit Care Med 1992; 20:493-498

(42) Osterwalder JJ. Patients intoxicated with heroin or heroin mixtures: how long should they be monitored? Eur J Emerg Med 1995; 2:97-101

(43) Christenson J, Etherington J, Grafstein E, et al. Early discharge of patients with presumed opioid overdose: development of a clinical prediction role. Acad Emerg Med 2000; 7:1110-1118

(44) Goldfrank L, Weisman R. Opioids. In: Goldfrank LR, Flomenbaum NE, Lewin N, et al, eds. Goldfrank's toxicologic emergencies. 6th ed. Norwalk, CT: Appleton & Lange, 1994; 769-783

(45) Karliner J. Noncardiogenic forms of pulmonary edema. Circulation 1972; 156:212-215

(46) Gopinathan K, Saroja D, Spears R, et al. Hemodynamic studies in heroin-induced acute pulmonary edema [abstract]. Circulation 1970; III-44:61-63

(47) Katz S, Aberman A, Frand UI, et al. Heroin pulmonary edema: evidence for increased pulmonary capillary permeability. Am Rev Respir Dis 1972; 106:472-474

(48) Hakim TS, Grunstein MM, Michel RP. Opiate action in the pulmonary circulation. Pulm Pharmacol 1992; 5:159-165

(49) Pietra GG, Szidon JP, Leventhal MM, et al. Histamine and interstitial pulmonary edema in the dog. Circ Res 1971; 29:323-337

(50) Brashear RE, Kelly MT, White AC. Elevated plasma histamine after heroin and morphine. J Lab Clin Med 1974; 83:451-457

(51) Schurig J, Cavanagh R, Buyniski J. Effect of butorphanol and morphine on pulmonary mechanics, arterial blood pressure and venous plasma histamine in the anesthetized dog. Arch Int Pharmacodyn Ther 1978; 233:296

(52) Philbin DM, Moss J, Akins CW, et al. The use of [H.sub.1] and [H.sub.2] histamine antagonists with morphine anesthesia: a double-blind study. Anesthesiology 1981; 55:292-296

(53) Fahmy NR. Hemodynamics, plasma histamine, and catecholamine concentrations during an anaphylactoid reaction to morphine. Anesthesiology 1981; 55:329-331

(54) Rosow CE, Moss J, Philbin DM, et al. Histamine release during morphine and fentanyl anesthesia. Anesthesiology 1982; 56:93-96

(55) Moss J, Rosow CE. Histamine release by narcotics and muscle relaxants in humans. Anesthesiology 1983; 59:330-339

(56) Barke KE. Opiates, mast cells, and histamine release. Life Sci 1993; 53:1391-1399

(57) Withington DE, Patrick JA, Reynolds F. Histamine release by morphine and diamorphine in man. Anesthesia 1993; 48: 26-29

(58) Brigham KL, Owen PJ. Increased sheep lung vascular permeability caused by histamine. Circ Res 1975; 37:647-657

(59) Pietra GG, Magno M, Johns L. Morphological and physiological study of the effect of histamine on the isolated perfused rabbit lung. Lymphology 1979; 12:165-176

(60) Edston E, van Hage-Hamsten M. Anaphylactoid shock: a common cause of death in heroin addicts? Allergy 1997; 52:950-954

* From the Department of Medicine (Dr. Sporer), University of California, San Francisco, San Francisco General Hospital, San Francisco; and Department of Emergency Medicine (Dr. Dorn), Alameda County Medical Center/Highland Campus, University of California, San Francisco, San Francisco, CA.

Manuscript received August 3, 2000; revision accepted May 1, 2001.

Correspondence to: Karl A. Sporer, MD, Emergency Services, Room 1E21, San Francisco General Hospital, 1001 Potrero Ave, San Francisco, CA 94110; e-mail: Ksporer@itsa.ucsfedu

COPYRIGHT 2001 American College of Chest Physicians
COPYRIGHT 2001 Gale Group

Return to Nalbuphine
Home Contact Resources Exchange Links ebay